Incidence and phenotypes of childhood-onset genetic epilepsies: a prospective population-based national cohort
Open accessThe DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
Abstract
Epilepsy is common in early childhood. In this age group it is associated with high rates of therapy-resistance, and with cognitive, motor, and behavioural comorbidity. A large number of genes, with wide ranging functions, are implicated in its aetiology, especially in those with therapy-resistant seizures. Identifying the more common single-gene epilepsies will aid in targeting resources, the prioritization of diagnostic testing and development of precision therapy. Previous studies of genetic testing in epilepsy have not been prospective and population-based. Therefore, the population-incidence of common genetic epilepsies remains unknown. The objective of this study was to describe the incidence and phenotypic spectrum of the most common single-gene epilepsies in young children, and to calculate what proportion are amenable to precision therapy. This was a prospective national epidemiological cohort study. All children presenting with epilepsy before 36 months of age were eligible. Children presenting with recurrent prolonged (>10 min) febrile seizures; febrile or afebrile status epilepticus (>30 min); or with clusters of two or more febrile or afebrile seizures within a 24-h period were also eligible. Participants were recruited from all 20 regional paediatric departments and four tertiary children’s hospitals in Scotland over a 3-year period. DNA samples were tested on a custom-designed 104-gene epilepsy panel. Detailed clinical information was systematically gathered at initial presentation and during follow-up. Clinical and genetic data were reviewed by a multidisciplinary team of clinicians and genetic scientists. The pathogenic significance of the genetic variants was assessed in accordance with the guidelines of UK Association of Clinical Genetic Science (ACGS). Of the 343 patients who met inclusion criteria, 333 completed genetic testing, and 80/333 (24%) had a diagnostic genetic finding. The overall estimated annual incidence of single-gene epilepsies in this well-defined population was 1 per 2120 live births (47.2/100 000; 95% confidence interval 36.9–57.5). PRRT2 was the most common single-gene epilepsy with an incidence of 1 per 9970 live births (10.0/100 000; 95% confidence interval 5.26–14.8) followed by SCN1A: 1 per 12 200 (8.26/100 000; 95% confidence interval 3.93–12.6); KCNQ2: 1 per 17 000 (5.89/100 000; 95% confidence interval 2.24–9.56) and SLC2A1: 1 per 24 300 (4.13/100 000; 95% confidence interval 1.07–7.19). Presentation before the age of 6 months, and presentation with afebrile focal seizures were significantly associated with genetic diagnosis. Single-gene disorders accounted for a quarter of the seizure disorders in this cohort. Genetic testing is recommended to identify children who may benefit from precision treatment and should be mainstream practice in early childhood onset epilepsy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Loss-of-function (LOF) missense or truncating variants cause Dravet syndrome, the prototypic DEE 13,27 , and also the non-DEE syndrome of Genetic Epilepsy with Febrile Seizures Plus (GEFS+) 28 .”
From Developmental and epileptic encephalopathies (2024) · cites this paper as [13]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The incidence of syndromes associated with de novo genetic variants is likely to be similar around the world 13 ; whereas, recessive causes occur more frequently in populations with high rates of consanguinity 14 .”
From Developmental and epileptic encephalopathies (2024) · cites this paper as [13]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of protein-coding genetic variation in 60,706 humans
Exome Aggregation Consortium, Lek, M., Karczewski, K. J., Minikel, E. V., Samocha, K. E., Banks, E., Fennell, T., O’Donnell-Luria, A. H., Ware, J. S., Hill, A. J., et al. (2016) · Nature · doi:10.1038/nature19057 · Cited by 9,587
Early Identification of Refractory Epilepsy
Kwan, P., & Brodie, M. J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200002033420503 · Cited by 5,204
Scheffer, I. E., Berkovic, S., Capovilla, G., Connolly, M. B., French, J., Guilhoto, L., Hirsch, E., Jain, S., Mathern, G. W., Moshé, S. L., et al. (2017) · Epilepsia · doi:10.1111/epi.13709 · Cited by 5,054 · cited 1×
“The concept of the ‘developmental and epileptic encephalopathy’ (DEE) recognizes that in children presenting with early-onset epilepsy, neurodevelopmental comorbidity may be attributable to both the underlying cause and to the detrimental effects of uncontrolled epileptic activity (Scheffer et al., 2017).”
Self-citationIncidence of Epilepsy and Unprovoked Seizures in Rochester, Minnesota: 1935–1984
Hauser, W. A., Annegers, J. F., & Kurland, L. T. (1993) · Epilepsia · doi:10.1111/j.1528-1157.1993.tb02586.x · Cited by 2,073
Prevalence and incidence of epilepsy: A systematic review and meta-analysis of international studies
Fiest, K. M., Sauro, K. M., Wiebe, S., Patten, S. B., Kwon, C.-S., Dykeman, J., Pringsheim, T., Lorenzetti, D. L., & Jetté, N. (2017) · Neurology · doi:10.1212/wnl.0000000000003509 · Cited by 1,902
Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
Devinsky, O., Cross, J. H., Laux, L., Marsh, E., Miller, I., Nabbout, R., Scheffer, I. E., Thiele, E. A., & Wright, S. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1611618 · Cited by 1,711
Estimation of the burden of active and life-time epilepsy: a meta-analytic approach
Ngugi, A. K., Bottomley, C., Kleinschmidt, I., Sander, J. W., & Newton, C. R. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2009.02481.x · Cited by 1,447 · cited 1×
“, 2017) and that 50–65 million individuals are affected worldwide (Ngugi et al., 2010; Fiest et al., 2017).”
A Potassium Channel Mutation in Neonatal Human Epilepsy
Biervert, C., Schroeder, B. C., Kubisch, C., Berkovic, S. F., Propping, P., Jentsch, T. J., & Steinlein, O. K. (1998) · Science · doi:10.1126/science.279.5349.403 · Cited by 1,073 · cited 1×
“The literature describes two distinct phenotypes associated with KCNQ2 variants: a self-limited familial neonatal seizure phenotype (Biervert et al., 1998; Singh et al., 2003) and a severe neonatal-onset developmental and epileptic encephalopathy (Weckhuysen et al.”
Effect of Cannabidiol on Drop Seizures in the Lennox–Gastaut Syndrome
Devinsky, O., Patel, A. D., Cross, J. H., Villanueva, V., Wirrell, E. C., Privitera, M., Greenwood, S. M., Roberts, C., Checketts, D., VanLandingham, K. E., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1714631 · Cited by 1,015 · cited 2×
“Cannabidiol also has efficacy in Lennox Gastaut syndrome (French et al., 2017; Devinsky et al., 2018), an epilepsy with varied aetiologies.”
Self-citationDevinsky, O., Cilio, M. R., Cross, H., Fernandez‐Ruiz, J., French, J., Hill, C., Katz, R., Di Marzo, V., Jutras‐Aswad, D., Notcutt, W. G., et al. (2014) · Epilepsia · doi:10.1111/epi.12631 · Cited by 1,000 · cited 1×
“In Dravet syndrome cannabidiol demonstrates efficacy (Devinsky et al. , 2017); however, there is no biological reason why cannabidiol should be specifically effective in this condition because it does not appear to act on sodium channels or GABA receptors (Devinsky et al. , 2014).”
Research works printed but not linked: 1
- The Broad Institute: Cambridge MA 2018. gnomAD Browser. http://gnomad.broadinstitute.org/(April 2018, date last accessed).
Cited by
Items 401–456 of 456
Abbott, M., Bender, K. J., Brunklaus, A., Demarest, S., Egan, S. M., Haviland, I., Kearney, J. A., Myers, L. S., Olson, H. E., Sanders, S., et al. (2024) · Cambridge University Press eBooks · doi:10.1017/9781009530361 · Cited by 4
Self-citationYalçın, G., Yıldırım, R., Ünal, E., Cebeci, D., Ersen, A., Özyılmaz, B., Tekeş, S., Anıl, M., & Gürbay, A. (2024) · Research Square · doi:10.21203/rs.3.rs-5375557/v1
Research Progress on Precise Diagnosis and Treatment of Developmental and Epileptic Encephalopathies
杨, 涵. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.151002
Joshi, S., & Lal, D. (2024) · Springer eBooks · doi:10.1007/978-3-031-77741-7_9
Tang, M., Teng, S., Kim, A. Y., Peng, Y., & Monani, U. R. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.05.647372
Yang, J., Huang, Y., Chen, Z., Peng, J., Li, K., Huang, L., Yang, J., & Yang, C. (2025) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2025.102008
Jacoby, P. A., Marsh, E. D., Demarest, S., Saldaris, J. M., Leonard, H., Olson, H. E., Saby, J. N., Pestana‐Knight, E., Rajaraman, R. R., Price, D., et al. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5246530
Cilio, M. R., Carapancea, E., & Sands, T. T. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-10944-7.00084-6
Ruggiero, S. M., & Helbig, I. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-10944-7.00051-2
Josh, G. D. S., Ramesh, S., Priya Margaret, A., Ramesh, J., & Sathees, P. (2025) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20251758
Diagnosis and Treatment of Epilepsy Syndromes
Yan, Y., Wang, Y., Xiao, F., Wang, X., Zhang, H., Hu, Y., Luo, R., Jiang, L., Wu, Y., Liu, X., et al. (2025) · Springer eBooks · doi:10.1007/978-981-96-8520-2_5 · Cited by 1
Zhang, M.-J., Zhang, S.-M., Zhang, Q.-P., Wen, Y., Wang, J.-P., Xiong, H., Jiang, Y.-W., & Bao, X. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1638549
Global burden of epilepsy in children from 1990 to 2021 and trend forecast in the post-pandemic era
Teng, H., Yan, O., Xiao, C., Wang, X., Chen, H., Liu, Z., & Xu, J. (2025) · Science China Life Sciences · doi:10.1007/s11427-025-3057-3
Nguyen-Martinez, A. L., Jolliffe, M., Scimeca, L. M., Park, K., Demarest, S., Knupp, K. G., Angione, K. M., & Miele, A. S. (2025) · Child Neuropsychology · doi:10.1080/09297049.2025.2591632
Downs, J. A., Keeley, J., Jacoby, P. A., Benson‐Goldberg, S., Pillar, S. V., Miele, A., Leonard, H., Saldaris, J. M., Marsh, E. D., Benke, T. A., et al. (2025) · Journal of Patient-Reported Outcomes · doi:10.1186/s41687-025-00977-z · Cited by 1
Das, N., Mohamed, A. A., Katyayan, A., & Vessell, M. (2025) · Pediatric Neurosurgery · doi:10.1159/000549985 · Cited by 2
Cholinergic modulation of hippocampal CA1 pyramidal cell excitability in ArxGCG+7 mice
Johnson, C. M., Dong, J., Senkungu, P., Chandar, J., Ochoa-Sepulveda, N., Myers, A. J., & Marsh, E. D. (2025) · Experimental Neurology · doi:10.1016/j.expneurol.2025.115591
Computational Study of Cannabis Derivatives in the Treatment of Dravet Syndrome
Bhattacharya, A., & Modak, S. (2024) · doi:10.52756/bhietm.2024.v03.004
Shim, Y., Yang, D. H., Eun, B., & Byeon, J. H. (2025) · Annals of Child Neurology · doi:10.26815/acn.2025.01060
Case Report: Glucose transporter 1 deficiency syndrome misdiagnosed as bacterial meningitis
Wang, M., Wang, C., Shang, L., Feng, Y., Huang, D., Li, Q., Wang, J., Guo, H., & Wang, Y. (2026) · Frontiers in Pediatrics · doi:10.3389/fped.2025.1698163 · Cited by 1
Armeno, M. L., Massaro, M., Boccoli, J., Caballero, E., Chacón, S., Diz, M., Espeche, A., Fasulo, L., Galarza, N., Gonzalez, L., et al. (2026) · Epileptic Disorders · doi:10.1002/epd2.70187
KCC2 activation during postnatal development alleviates long-term deficits in CDKL5-deficient mice
Arshad, M. N., Bope, C. E., Cho, N., Dengler, J. S., Ng, J., Smalley, J. L., Nishi, T., Zhong, Z., Moss, S. J., & Davies, P. A. (2026) · Experimental & Molecular Medicine · doi:10.1038/s12276-026-01670-x · Cited by 3
Ngoh, A. S. F., Wei, H., Yeo, T. H., Krishnappa, J., Ling, S. R., Tan, E., & Chan, D. W. S. (2026) · Molecular Syndromology · doi:10.1159/000550657
Coupling of functionality to trafficking of KCNQ2/3 potassium channels at the axon initial segment
Yoshioka, D., & Okamura, Y. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2527749123 · Cited by 3
Tamura, S., Shimbo, H., Aruga, N., Kawaguchi, M., Okado, H., Yasuda, Y., Miyaoka, Y., Sasakura, A., Matsuo, K., Nishihara, H., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.04.709430
Global burden of epilepsy attributable to neonatal disorders in children from 1990 to 2021
Zhong, S., Lian, Y., Yi, H., Jia, K., Zhang, N., Kwan, P., Yang, Y., & Tian, X. (2026) · iScience · doi:10.1016/j.isci.2026.115296 · Cited by 1
Wheless, J. W., Shahid, A. M., & Vidaurre, J. A. (2026) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2026.03.019
Mihaylov, S. R., Lopes, A. T., Silvestre, M., Bianchini, G., Flynn, H. R., Huseynova, A., Strohbuecker, S., Griffith, L., Militti, C., Baltussen, L. L., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.07.716766
BKCa channels as therapeutic targets in neurodevelopmental disorders : focus on acoustic dysfunction
Ferraguto, C. (2024) · theses.fr (ABES) · doi:10.70675/38217611z1b01z43f4zb4b0z72d28aca79c3
Mattei, C., Mao, M., Byars, S., Syazwan, E. S. M., Oliva, M., Karle, T. J., Richards, K., Scheffer, I. E., Petrou, S., & Maljevic, S. (2026) · Epilepsia · doi:10.1002/epi.70267 · Cited by 2
Setouani, S., Khabbach, K., Lamzouri, A., Boussaadni, Y. E., & Oulmaati, A. (2026) · Cureus · doi:10.7759/cureus.108475
Особенности использования противосудорожной терапии у детей раннего возраста
Лебедев, А. В., & Кащевская, В. М. (2026) · International journal of medicine and psychology. · doi:10.58224/2658-3313-2026-9-3-12-21
EEG in the diagnosis and management of early childhood epilepsies
Zaddach, M., Borggraefe, I., Craiu, D., & Eisermann, M. (2026) · Clinical Epileptology · doi:10.1007/s10309-026-00850-z
Morris, H., Mathew, E., Bahl, S., Villa‐Lopez, M., & Mercimek‐Andrews, S. (2026) · Epilepsia Open · doi:10.1002/epi4.70269
Vigabatrin-Associated Brain Abnormalities on MRI in a Patient with PCDH19-Clustering Epilepsy
Apanasenko, O., Głodek-Brzozowska, E., Guz, P., Łobodzińska, A., & Perenc, L. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15124619
Lim, Y., & Hur, Y. J. (2026) · Annals of Child Neurology · doi:10.26815/acn.2026.01466
Karaer, D., Yüzbaşı, B. K., Sahin, İ., Güngör, O., & Karaer, K. (2026) · Epileptic Disorders · doi:10.1002/epd2.70277
Dosbolova, M., Ayaganov, D. N., Sakhanova, S., Jaxybayeva, A., Lepessova, M., Adebietova, A., Mamedbayli, A., & Zhussupova, Z. (2026) · Медицинский журнал Западного Казахстана · doi:10.4103/wkmj.wkmj_63_26
Yaman, B., Kürekçi, F., Akbaş, S., Oney, C., Kılıç, M. A., Genç, H. M., Aslanger, A. D., & Yıldız, E. P. (2026) · Epileptic Disorders · doi:10.1002/epd2.70356
Epilepsy‐Dyskinesia Syndromes: The Venn Diagram of Genetic Epilepsy and Movement Disorders
Bernardi, K., Alecu, J. E., Achkar, C. M. E., Tochen, L. S., Pearl, P. L., & Ebrahimi‐Fakhari, D. (2026) · Movement Disorders · doi:10.1002/mds.70403 · Cited by 2
Epilepsy and education: a nationwide cohort study
Böttger, M. T. W., Trabjerg, B. B., Dreier, J. W., & Christensen, J. (2026) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2026-338791 · Cited by 1
Kayar, Ç. D., Akbaş, S., Kürekçi, F., Yaman, B., Kılıç, M. A., Genç, H. M., & Yıldız, E. P. (2026) · Epileptic Disorders · doi:10.1002/epd2.70382
Sobrinho, L. M. F., Fontana, J. C., Lorea, C. F., van der Linden, H., Leite, A. C. S., Maia, R. E., Refosco, L. F., de Souza, C. F. M., Poloni, S., Poswar, F. D. O., et al. (2026) · JIMD Reports · doi:10.1002/jmd2.70113
Wang, S., Du, J., Liu, J., Hu, D., Wang, H., Man, X., Gao, L., Hu, S., Meng, X., Zhao, H., et al. (2026) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.70517
Carapancea, E., Semal, B., Merci, N., Pugliano, R., Sands, T. T., Cilio, M. R., & Aeby, A. (2026) · Seizure · doi:10.1016/j.seizure.2026.08.028
Zhou, J., Kurahashi, H., Numoto, S., Azuma, Y., Takeo, T., Fukasawa, T., Hiraki, A., Maki, Y., Tanaka, M., Yamamoto, H., et al. (2026) · Seizure · doi:10.1016/j.seizure.2026.09.003
Sattaporn, C., Lusawat, A., Sudachan, P., Rojanawatsirivej, A., Vatanavicharn, N., Liammongkolkul, S., lttiwut, R., lttiwut, C., Od‐Ek, P., Srichomthong, C., et al. (2026) · Brain and Development · doi:10.1016/j.braindev.2026.104593
Escobar-Montalvo, J. M., Torres, A. M., Escobar-Ipuz, F. A., & Mateo, J. (2026) · Seizure · doi:10.1016/j.seizure.2026.09.013
Li, J., Fan, W., Liu, N., Zhang, S., Wang, P., Gu, C., & Shu, J. (2026) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.70305
Iglesias, M., & Sherin, K. (2026) · Cureus · doi:10.7759/cureus.117344
Febrile seizures in pediatrics
Steinbrücker, K., & Koch, J. (2026) · Clinical Epileptology · doi:10.1007/s10309-026-00869-2
Genetic developmental and epileptic encephalopathies in adulthood: Gaps in evidence and care
Dudley, A. M., Widdess‐Walsh, P., Linehan, C., Andrade, D. M., Delanty, N., & Moloney, P. B. (2026) · Epilepsia Open · doi:10.1002/epi4.70359
Abumansour, I. S., Daghistani, R. O., Muthaffar, O. Y., & Alyazidi, A. S. (2026) · Journal of Applied Genetics · doi:10.1007/s13353-026-01125-z
BindingDB Entry 50020695: Advances in Epilepsy: Mechanisms, Clinical Trials, and Drug Therapies.
BindingDB (2024) · UC San Diego · doi:10.7270/q2sq94v8
Metadata
- Authors
- Symonds, J. D., Zuberi, S. M., Stewart, K., McLellan, A., O‘Regan, M., MacLeod, S., Jollands, A., Joss, S., Kirkpatrick, M., Brunklaus, A., Pilz, D. T., Shetty, J., Dorris, L., Abu-Arafeh, I., Andrew, J., Brink, P., Callaghan, M., Cruden, J., Diver, L. A., Findlay, C., Gardiner, S., Grattan, R., Lang, B., MacDonnell, J., McKnight, J., Morrison, C. A., Nairn, L., Slean, M. M., Stephen, E., Webb, A., Vincent, A., & Wilson, M.
- Affiliations
- Royal Hospital for Children (GB)
- Queen Elizabeth University Hospital (GB)
- Paediatric Neurosciences Research Group, Royal Hospital for Children, Glasgow, UK
- NHS Tayside (GB)
- Department of Paediatrics, Forth Valley Royal Hospital, Larbert, UK
- Wishaw General Hospital (GB)
- Victoria Hospital (GB)
- University Hospital Crosshouse (GB)
- Forth Valley Royal Hospital (GB)
- John Radcliffe Hospital (GB)
- Borders General Hospital (GB)
- Dumfries and Galloway Royal Infirmary (GB)
- Royal Alexandra Hospital (GB)
- University of Glasgow (GB)
- Royal Aberdeen Children's Hospital (GB)
- Raigmore Hospital (GB)
- Corresponding author
- Zuberi, Sameer M
- ORCID
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2019-07-13
- Volume
- 142
- Issue
- 8
- Pages
- 2303-2318
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- PMC
- PMC6658850
- OpenAlex
- W2961503558
- Cited by
- 459
- References
- 81
- Citations by year
- 2026: 49 · 2025: 82 · 2024: 87 · 2023: 67 · 2022: 76 · 2021: 44 · 2020: 48 · 2019: 6
- FWCI
- 34.58
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Brain (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Discovery Research Portal (University of Dundee) (publishedVersion, cc-by-nc)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion, cc-by-sa)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
- Funders
- Epilepsy Research UK
- Dravet Syndrome UK
- Topics
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmacological Effects and Toxicity Studies
- Keywords
- childhood-onset epilepsy, genetic epilepsy, incidence, phenotypic spectrum, PRRT2, SCN1A, KCNQ2, KCNQ3, KCNA2, KCNA1, Kv1.3 potassium channel, Kv1.5, KC
- MeSH terms
- Child, Preschool, Epilepsy, Female, Humans, Infant, Infant, Newborn, Male, Phenotype, Prospective Studies, Scotland, Cohort Studies, Incidence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.